Results 1 to 1 of 1
05-23-2013, 08:12 AM #1
- Join Date
- Aug 2012
- Merced, CA 95348-1422
- Blog Entries
Recall: Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx
Product Description Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, UPC 3 61958 01011 5; NDC 61958-0101-1.
Recall Number D-324-2013
Classification Class I
Code Info Lot #: B120217A, Exp 05/15 - US Distribution
Product Distributed Qty 3,181 vials
Reason For Recall Presence of Particulate Matter: Particulate matter was found in some vials of Vistide (cidofovir injection).
Event Id 64267
Product Type Drugs
Recalling Firm Gilead Sciences, Inc., Foster City, CA, USA
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2013-01-31
Initial Firm Notification of Consignee or Public E-Mail
Distribution Pattern Nationwide in USA, Canada, and UK (Gilead facility in Cork Ireland). Cork facility distributed to Germany/Austria, Italy and Spain.